Skip to main content

News

Press release year list 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008
09/17/2021
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
08/31/2021
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
08/06/2021
ANI Pharmaceuticals Reports Second Quarter 2021 Results
07/22/2021
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
07/06/2021
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
06/15/2021
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
06/01/2021
ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
05/27/2021
ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
05/07/2021
ANI Pharmaceuticals Reports First Quarter 2021 Results
04/26/2021
ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
04/06/2021
ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs
03/09/2021
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth
DownloadPDF format download (opens in new window)
03/09/2021
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
DownloadPDF format download (opens in new window)
02/19/2021
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/17/2021
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
02/16/2021
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
02/01/2021
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules